Dr. Emily Kay-Rivest, a cochlear implant surgeon, holds the transmitter that usually adheres magnetically to the head of her JGH patient, Diana Wood. The transmitter relays sound (in the form of electrical impulses) to a receiver under the skin near Ms. Wood’s ear. Ultimately, the impulses reach a nerve that connects to the brain. (Click on this or any photo to enlarge it.)
Feature articlesSeptember 2024

Cochlear implant now an easier option for JGH patients hoping to overcome deafness

To regain their hearing, many patients are opting for a cochlear implant, performed by a surgical team that includes a JGH otolaryngologist.

READ MORE →
Dr. William Foulkes
December 2023Milestones

Dr. William Foulkes appointed JGH Director of Medical Genetics

Dr. William Foulkes, an award-winning clinician-researcher at the Lady Davis Institute, has been appointed JGH Director of Medical Genetics.

READ MORE →
Dr. Claudia Kleinman
January 2023Research at the Lady Davis Institute

Researchers inch closer to better understanding of brain tumours in children

Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.

READ MORE →
Dr. William Foulkes (Photo courtesy of McGill University)
November 2020Research at the Lady Davis Institute

LDI researcher wins top honour for research in biomedicine

Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.

READ MORE →
Maxime Rémillard
Feature articlesOctober 2020

Major donation for research consortium to improve outcomes of lung cancer patients

A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.

READ MORE →
Dr. Lawrence Rosenberg
April 2016Research at the Lady Davis Institute

Landmark clinical trial under way for type 1 diabetes treatment

Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.

READ MORE →